期刊文献+

光动力治疗骨与软组织肉瘤的疗效及其机制 被引量:5

Antitumor effect and mechanism of hematoporphyrin monomethyl ether mediated photodynamictherapy on sarcoma
原文传递
导出
摘要 目的探讨血卟啉单甲醚介导光动力疗法(hematopotphyrin monomethyl ether induced photodynamic therapy,HMME-PDT)的抗肉瘤效应及其机制。方法流式细胞仪检测骨肉瘤细胞和成肌细胞的胞内HMME摄取,MTT法检测骨与软组织肉瘤细胞存活率,流式细胞术检测骨肉瘤细胞凋亡率,Hoechst33342染色法观察细胞凋亡,不可逆caspase通路抑制刹及坏死抑制剂检测PDT介导的细胞死亡形式,蛋白免疫印迹和免疫组化检测肿瘤细胞中caspase-l、-3、-6、-9、PARP蛋白相对表达量,测定瘤体体积及瘤重评估PDT的抗肿瘤效应,HE染色检测肿瘤组织形态学改变。结果光敏剂HMME选择性的聚集于骨肉瘤细胞中,而正常细胞摄取较少,且骨肉瘤细胞的摄取呈孵育时间及浓度依赖性。HMME-PDT能显著杀伤骨与软组织肉瘤细胞。HMME-PDT可明显诱导贴壁及悬浮培养骨肉瘤细胞发生凋亡。Hoechst33342染色可见典型的捌亡改变。凋亡是HMME-PDT介导的细胞死亡的主要形式,且与easpase依赖的凋亡通路密切相关。HMME-PDT可明显上调easpase-1、-3、-6、-9、PARP蛋白表达寄HMME-PDT组肿瘤体积及瘤重均较空白组明显减小,且肿瘤区域出现广泛坏死。结论HMME-PDT能有效地抑制肉瘤生长,其抗肉瘤效应与caspase依赖的凋亡通路密切相关。 Objective To investigate the effect and mechanism of hematoporphyrin monomethylether mediated photodynamic therapy (HMME-PDT) on sarcoma. Methods Tile intracellular uptake of HMME on osteosareoma cells (LM8) and myoblast ceils (C2C12) using flow cytometry method. The bone and soft sarcoma cells viability was measured by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyhetrazolium bromide (MTT) assay. The apoptosis of osteosarcoma cells were detected by flow cytometry method with Annexin V- FITC/PI staining. The apoptnsis of cells was fnrther observed by Hoechst 33342 staining. The irreversible inhibitor of caspase (Z-VAD-FMK) and necrosis (Nec-l) was performed to detect the type of PDT-mediated cell death. The relative expression levels of caspase-l, 3, 6, 9 and PARP were detected by Western blotting and immunohistochemistry (IHC). The efficacy of antitumor was evaluated by the size and the weight and Hematoxylin eosin (HE) staining was used to observe the histological changes of tumor. Results HMME can se- lectively accumulate in osteosarcoma cells while normal cells absorbed much less. HMME-PDT can markedly killed the sarcoma cells and the killing effect increased with HMME concentration and energy intensity. The apoptosis rates in HMME-PDT groups significantly increased both adherent and suspension cells. It was observed typical changes, by Hoechst 33342 stained. The results showed that apoptosis was the major form of cells death and might be closely with caspase-dependent apoptosis after HMME-PDT. The expression levels of caspase-l, 3, 6, 9 and PARP were significantly up-regulated in the treatment grnups. Comparing with the blank group, the tumor volume and the tumor weight were markedly decreased. The widespread necrotic areas were observed by HE staining in tumor. Conclusion HMME-PDT significantly inhibited the tumor growth in vivo, which are closely correlated with caspase-dependent pathway.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2013年第5期584-592,共9页 Chinese Journal of Orthopaedics
基金 上海市科学技术委员会基金(11JC1410101)
关键词 血卟啉光照疗法 血卟啉类 骨肉瘤 肉瘤 Hematoporphyrin photoradiation Hematoporphyrins Osteosarcoma Sarcoma
  • 相关文献

参考文献14

  • 1Reiners JJ Jr, Agostinis P, Berg K,et al. Assessing autophagy inthe context of photodynamic therapy. Autophagy, 2010,6 (1): 7-18.
  • 2Nowak-Sliwinska P, van Beijnum JR, van Berkel M, et al. Vascu-lar regrowth following photodynamic therapy in the chicken em-bryo chorioallantoic membrane. Angiogenesis, 2010, 13 (4): 281-292.
  • 3Cai H,Gu Y,Sun Q, et al. Eefut of hematoporphyrinmonomethyl ether-mediated photodynamic therapy on hyper-trophic scar fibroblasts. Photodermatol Photoimmunol Photomed,2011,27(2): 90-96.
  • 4Ding X,Xu Q, Liu F, et al. Hematoporphyrin monomethyl etherphotodynamic damage on HeLa cells by means of reactive oxygenspecie production and cytosolic free calcium concentration ele-vation. Cancer Lett, 2004, 216(1): 43-54.
  • 5Yanase S, Nomura J, Matsumura Y, et al. Synergistic increase inoste<.arcoma cell sensitivity to photodynamic therapy withaminolevulinic acid hexyl ester in the presence of hypertheimia.Photomed Laser Surg, 2009, 27(5): 791-797.
  • 6Matsubara T, Kusuzaki K, Matsumine A, et al. Clinical outcomesof minimally involve surgery using acridine orange for muscu-loskeletal sarcomas around the forearm, compared with conven-tional limb salvage surgery after wide resection. J Surg Oncol,2010, 102(3): 271-275.
  • 7蔡郑东,胡硕,龚海洋,孙梦熊,李国东,李健.PSD-007介导的光动力疗法治疗小鼠骨肉瘤的实验研究[J].中华骨科杂志,2011,31(6):692-698. 被引量:5
  • 8胡硕,孙梦熊,高博,蔡郑东,张治宇.光敏剂HpD、PSD-007对小鼠骨肉瘤的光动力作用[J].中国激光医学杂志,2010,19(3):148-151. 被引量:3
  • 9孙梦熊,胡硕,孙伟,蔡郑东.癌光啉对人骨肉瘤MG-63细胞的光动力杀伤效应[J].上海医学,2010,33(6):558-561. 被引量:5
  • 10Hsieh YJ, Wu CC,Chang CJ, et al. Subcellular localization ofPhotofrin deteraiines the death phenotype of human epidermoidcarcinoma A431 cells triggered by photodynamic therapy: whenplasma membranes are the main targets. J Cell Physiol, 2003,194(3): 363-375.

二级参考文献38

  • 1Huang Z.A review of progress in clinical photodynamic therapy[J].Technol Cancer Res Treat,2005,4:283-294.
  • 2Selman SH.Photodynamic therapy for prostate cancer:one urologist's perspective[J].Photodiag Photodyn Ther,2007,4:26-30.
  • 3Muller PJ,Wilson BC.Photodynamic therapy of brain tumors:a work in progress[J].lasers Surg MOd,2006,38:384-389.
  • 4Huang Z.Photodynamic therapy in China:25 years of unique history.Part two:Clinical experience[J].Photodiag Photodyn Ther,2006,3:71-84.
  • 5Biel M.Advances in photodynamic therapy for the treatment of head and neck cancers[J].Lasers Surg Med,2006,38:349-355.
  • 6Kusuzaki K,Suginoshita T,Minami G,et al.Fhorovisualization effect of acridine orange on mouse osteosarcoma[J].Anticancer Res,2000,20:3019-3024.
  • 7Henderson BW,Fingar VH.Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model[J].Photochem Photobiol,1989,49:299-304.
  • 8Nakamura T,Kusuzaki K,Matsubara T,et al.A new limh salvage surgery in cases of high-grade soft tissue sarcoma using photodynamic surgery,followed by photo-and radiodynamic therapy with acridine orange[J].J Surg Oncol,2008,97:523-528.
  • 9Dolmans D E,Kadambi A,Hill J S,et al.Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy.Cancer Res,2002,62:4289-4294.
  • 10Henderson B W,Dougherty T J.How dose photodynamic therapy work? Photochem Photobiol,1992,55:145-157.

共引文献10

同被引文献55

  • 1杨湘越.骨肉瘤实验室诊断研究现状及对策[J].中华临床医师杂志(电子版),2012,6(21):6841-6842. 被引量:8
  • 2张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:129
  • 3Gaspar N,Di Giannatale A,Geoerger B,et al.Bone sarcomas:from biology to targeted therapies.Sarcoma,2012,2012:301975.
  • 4Xu XL,Gou WL,Wang AY,et al.Basic research and clinical applications of bisphosphonates in bone disease:what have we learned over the last 40 years? J Transl Med,2013,11:303.
  • 5Sabatino R,Antonelli A,Battistelli S,et al.Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells.PLoS One,2014,9(6):e101260.
  • 6Wang X,Yang KH,Wanyan P,et al.Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment:A meta-analysis of randomized controlled trials.Oncol Lett,2014,7(6):1997-2002.
  • 7Sun K,Wang J,Zhang J,et al.Dextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells.Int J Biol Macromol,2011,49(2):173-180.
  • 8Xu H,Niu X,Zhang Q,et al.Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model.Oncol Lett,2011,2(5):773-778.
  • 9Rodriguez CO Jr,Crabbs TA,Wilson DW,et al.Aerosol gemcitabine:preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.J Aerosol Med Pulm Drug Deliv,2010,23(4):197-206.
  • 10Valdez-Velázquez LL,Quintero-Hernández V,Romero-Gutiérrez MT,et al.Mass fingerprinting of the venom and transcriptome of venom gland of scorpion Centruroides tecomanus.PLoS One,2013,8(6):e66486.

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部